U.S. patent application number 14/999665 was filed with the patent office on 2016-10-13 for tri-tightening skin care formulation and related methods.
The applicant listed for this patent is Jules Zecchino. Invention is credited to Jules Zecchino.
Application Number | 20160296458 14/999665 |
Document ID | / |
Family ID | 55066178 |
Filed Date | 2016-10-13 |
United States Patent
Application |
20160296458 |
Kind Code |
A1 |
Zecchino; Jules |
October 13, 2016 |
Tri-tightening skin care formulation and related methods
Abstract
The present invention provides for a method or process for
manufacturing a formulation comprising: admixing at least one
hydrophilic polymer, at least one desquamatory agent and alpha
hydroxyl acid.
Inventors: |
Zecchino; Jules; (New York,
NY) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
Zecchino; Jules |
New York |
NY |
US |
|
|
Family ID: |
55066178 |
Appl. No.: |
14/999665 |
Filed: |
June 10, 2016 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
13998617 |
Nov 18, 2013 |
|
|
|
14999665 |
|
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61K 8/368 20130101;
A61Q 1/02 20130101; A61K 8/85 20130101; A61K 8/88 20130101; A61Q
19/00 20130101; A61K 8/606 20130101; A61K 8/365 20130101; A61K
2800/59 20130101; A61K 8/735 20130101; A61Q 19/08 20130101; A61K
8/60 20130101 |
International
Class: |
A61K 8/88 20060101
A61K008/88; A61K 8/365 20060101 A61K008/365; A61Q 19/08 20060101
A61Q019/08; A61K 8/60 20060101 A61K008/60 |
Claims
1. A formulation manufactured by a process comprising: providing at
least one hydrophilic polymer, at least one desquamatory agent and
alpha hydroxyl acid; increasing the molecular weight of said
hydrophilic polymer; crosslinking said hydrophilic polymer;
increasing the molecular weight of said alpha hydroxyl acid; and
admixing said hydrophilic polymer, said desquamatory agent and said
alpha hydroxyl acid to make a formulation.
2. The process of claim 1 further comprising admixing water.
3. The process of claim 1 wherein said hydrophilic polymer is
selected from a group consisting essentially of polyglutamic acid
(PGA), crosslinked polyglutamic acid, crosslinked hyaluronic acid,
cross-linked poly lactic acid, and combination and mixtures
thereof.
4. The process of claim 1 wherein said desquamatory agent is
selected from a group consisting essentially of N-acetyl
glucosamine (NAG), glucosamine, glucosamine hydrochloride and
combination and mixtures thereof.
5. The process of claim 1 wherein said alpha hydroxyl acid is
selected from a group consisting essentially of mandelic acid, and
combination and mixtures thereof.
6. The process of claim 1 wherein said hydrophilic polymer is from
about 0.05% to about 0.3%, said desquamatory agent is from about
0.05% to about 40% and said alpha hydroxyl acid is from about 0.05%
to about 30% of the formulation.
7. The process of claim 1 wherein said formulation can be used as a
product selected from a group consisting of skin care products,
cosmetics, cosmeceuticals, pharmaceuticals and nutriceuticals.
8. The process of claim 1 wherein said formulation is designed to
be combined with other components and ingredients to form a product
selected from a group consisting of skin care products, cosmetics,
cosmeceuticals, pharmaceuticals and nutriceuticals.
9. The process of claim 1 further comprising admixing at least one
activator selected from a group consisting essentially of Water,
Glycerin, Glycols, Polyols, Polyglutamic Acid, Hyaluronic Acid, and
combination and mixtures thereof.
10. The process of claim 1 further comprising admixing
preservatives, flavoring and coloring agents.
11. A method of manufacturing a formulation, said method
comprising: providing at least one hydrophilic polymer, at least
one desquamatory agent and alpha hydroxyl acid; increasing the
molecular weight of said hydrophilic polymer; crosslinking said
hydrophilic polymer; increasing the molecular weight of said alpha
hydroxyl acid; and admixing said hydrophilic polymer, said
desquamatory agent and said alpha hydroxyl acid to make a
formulation.
12. The method of claim 11 further comprising admixing water.
13. The method of claim 11 wherein said hydrophilic polymer is
selected from a group consisting essentially of polyglutamic acid
(PGA), crosslinked polyglutamic acid, crosslinked hyaluronic acid,
cross-linked poly lactic acid, and combination and mixtures
thereof.
14. The method of claim 11 wherein said desquamatory agent is
selected from a group consisting essentially of N-acetyl
glucosamine (NAG), glucosamine, glucosamine hydrochloride and
combination and mixtures thereof.
15. The method of claim 11 wherein said alpha hydroxyl acid is
selected from a group consisting essentially of mandelic acid, and
combination and mixtures thereof.
16. The method of claim 11 wherein said hydrophilic polymer is from
about 0.05% to about 0.3%, said desquamatory agent is from about
0.05% to about 40% and said alpha hydroxyl acid is from about 0.05%
to about 30% of the formulation.
17. The method of claim 11 wherein said formulation can be used as
a product selected from a group consisting of skin care products,
cosmetics, cosmeceuticals, pharmaceuticals and nutriceuticals.
18. The method of claim 11 wherein said formulation is designed to
be combined with other components and ingredients to form a product
selected from a group consisting of skin care products, cosmetics,
cosmeceuticals, pharmaceuticals and nutriceuticals.
19. The method of claim 11 further comprising admixing at least one
activator selected from a group consisting essentially of Water,
Glycerin, Glycols, Polyols, Polyglutamic Acid, Hyaluronic Acid, and
combination and mixtures thereof.
20. The method of claim 11 further comprising admixing
preservatives, flavoring and coloring agents.
Description
RELATED APPLICATION
[0001] This application is a divisional of U.S. patent application
Ser. No. 13/998,617 filed on Nov. 18, 2013 entitled "Tri-tightening
Skin Care Formulation".
BACKGROUND OF INVENTION
[0002] 1. Field of Invention
[0003] The present invention relates a skin care formulation and
related method of manufacture. In particular, the present invention
provides for a skin care formulation with a tri-tightening complex
including a hydrophilic polymer, a desquamatory agent and an alpha
hydroxyl acid.
[0004] 2. Description of Related Art
[0005] There are numerous prior art patents that disclose skin
tightening properties. The present invention provides for a skin
care formulation with a tri-tightening complex.
SUMMARY OF INVENTION
[0006] In one embodiment, the present invention provides for a
formulation comprising: at least one hydrophilic polymer, at least
one desquamatory agent and alpha hydroxyl acid.
[0007] In another embodiment, the hydrophilic polymer is selected
from a group consisting essentially of polyglutamic acid (PGA),
crosslinked polyglutamic acid, crosslinked hyaluronic acid,
cross-linked poly lactic acid, and combination and mixtures
thereof.
[0008] In yet another embodiment, the desquamatory agent is
selected from a group consisting essentially of N-acetyl
glucosamine (NAG), glucosamine, glucosamine hydrochloride and
combination and mixtures thereof.
[0009] In still another embodiment, the alpha hydroxyl acid is
mandelic acid.
[0010] In still yet another embodiment, the formulation further
comprises water. In a further embodiment, the formulation can be
used as a product selected from a group consisting of skin care
products, cosmetics, cosmeceuticals, pharmaceuticals and
nutriceuticals. In another further embodiment, the formulation can
be combined with other components and ingredients to form a product
selected from a group consisting of skin care products, cosmetics,
cosmeceuticals, pharmaceuticals and nutriceuticals.
[0011] In yet a further embodiment, the formulation further
comprises an activator selected from a group consisting essentially
of Water, Glycerin, Glycols, Polyols, Polyglutamic Acid, Hyaluronic
Acid, and combination and mixtures thereof. In still a further
embodiment, the formulation further comprises preservatives,
flavoring and coloring agents.
[0012] In still yet a further embodiment, the hydrophilic polymer
has increased molecular weight. In yet another further embodiment,
the hydrophilic polymer is cross-linked. In still another further
embodiment, the alpha hydroxyl acid has increased molecular
weight.
[0013] In still yet another embodiment, the present invention
relates to a composition comprising polyglutamic acid, mandelic
acid and N-acetyl glucosamine. In another embodiment, the
polyglutamic acid has increased molecular weight. In yet another
embodiment, the polyglutamic acid is cross-linked. In still another
embodiment, the alpha hydroxyl acid has increased molecular
weight.
[0014] In still yet another embodiment, the composition further
comprises water. In a further embodiment, the composition can be
used as a product selected from a group consisting of skin care
products, cosmetics, cosmeceuticals, pharmaceuticals and
nutriceuticals. In another further embodiment, the composition can
be combined with other components and ingredients to form a product
selected from a group consisting of skin care products, cosmetics,
cosmeceuticals, pharmaceuticals and nutriceuticals.
[0015] In yet a further embodiment, the composition further
comprises an activator selected from a group consisting essentially
of Water, Glycerin, Glycols, Polyols, Polyglutamic Acid, Hyaluronic
Acid, and combination and mixtures thereof.
[0016] In still a further embodiment, the composition further
comprises preservatives, flavoring and coloring agents.
[0017] In still yet a further embodiment, the formulation
manufactured by a process comprising: providing at least one
hydrophilic polymer, at least one desquamatory agent and alpha
hydroxyl acid; increasing the molecular weight of the hydrophilic
polymer; crosslinking the hydrophilic polymer; increasing the
molecular weight of the alpha hydroxyl acid; and admixing the
hydrophilic polymer, the desquamatory agent and the alpha hydroxyl
acid to make a formulation.
[0018] In another embodiment, the process further comprises
admixing water.
[0019] In another further embodiment, the hydrophilic polymer is
from about 0.05% to about 0.3%, said desquamatory agent is from
about 0.05% to about 40% and said alpha hydroxyl acid is from about
0.05% to about 30% of the formulation.
[0020] In yet another further embodiment, the formulation can be
used as a product selected from a group consisting of skin care
products, cosmetics, cosmeceuticals, pharmaceuticals and
nutriceuticals.
[0021] In still another embodiment, the formulation is designed to
be combined with other components and ingredients to form a product
selected from a group consisting of skin care products, cosmetics,
cosmeceuticals, pharmaceuticals and nutriceuticals.
[0022] In still yet another embodiment, the process further
comprises admixing at least one activator selected from a group
consisting essentially of Water, Glycerin, Glycols, Polyols,
Polyglutamic Acid, Hyaluronic Acid, and combination and mixtures
thereof.
[0023] In a further embodiment, the process further comprises
admixing preservatives, flavoring and coloring agents.
DETAILED DESCRIPTION OF THE INVENTION
[0024] As required, detailed embodiments of the present invention
are disclosed herein; it is to be understood that the disclosed
embodiments are merely exemplary of the invention that may be
embodied in various forms. Therefore, specific structural and
functional details disclosed herein are not to be interpreted as
limits, but merely as a basis for teaching one skilled in the art
to employ the present invention. The specific examples below will
enable the invention to be better understood. However, they are
given merely by way of guidance and do not imply any
limitation.
[0025] In one embodiment, the present invention uses Polyglutamic
acid (PGA) as the hydrophilic polymer. PGA has been used as a long
term skin hydrating, plumping material. The material helps bind
water to the skin, plumping the stratum corneum, adding to skin
firming and reducing lines and wrinkles.
[0026] These polymers have usually been in the one to two thousand
Dalton ranges with the maximum molecular weight of 10,000 Daltons.
Recently, breakthroughs in biotechnology have produced polymers in
the 2 to 3 million Dalton range. These high molecular weight PGAs
retain much more water on the skin than the lower molecular weight
ones. They actually hold more moisture than the Industry standard,
hyaluronic acids, that have molecular weights in the 2 million
Dalton range. In addition, a special grade of PGA was employed in
this invention. A PGA with a molecular weight of about 2 million
Daltons, that is additionally cross-linked. This cross-linking
helps render the polymer to be more long lasting on the skin
surface. It makes it less sensitive to degradation by skin enzymes
and other agents. The high molecular weight cross-linked PGA
provides a longer lasting firming and plumping effect than that of
other PGA's and hyaluronic acid.
[0027] In yet another embodiment, the present invention may use
Mandelic Acid which is a large molecular weight alpha hydroxy acid.
Mandelic acid contains an aromatic ring that makes it slow to
penetrate the upper layers of the stratum corneum. This helps to
have a much more prolonged effect on the skin than other alpha
hydroxy acids like glycolic or lactic acids. The skin resurfacing
action of mandelic acid has numerous benefits: firstly, it has been
shown to clip off dead surface skin cells, and secondly, makes the
action of PGA better by giving it a smooth undisturbed surface to
bind moisture to. Thusly, mandelic acid contributes to the skin
firming and smoothing benefits of the skin care formulations of the
present invention.
[0028] In still another embodiment, the desquamatory agent may be
N-acetyl glucosamine (NAG). NAG has shown to give excellent results
in skin smoothness, firming and reducing lines and wrinkles. It
acts as a natural skin desquamatory, gently clipping off skin
surface cells that are remaining on the surface too long. There
also appears to be a retinoid-like effect of increasing collagen
synthesis and improving dermal thickening. NAG assist in making the
skin denser and less lined and wrinkled. The addition of NAG to
mandelic acid and cross-linked PGA, appears to yield an optimum
amount of skin firming that is recognizable on test subjects in two
to four weeks.
[0029] The following examples are set forth below:
Example 1
Tri-Tightening Complex Formulation A
[0030] Phase A is weighed in a kettle equipped with high speed
agitation. Phase B is then added to Phase A and mixed until
homogenous. The ingredients and percentage of each ingredient in
the composition is set forth in Table 1 below:
TABLE-US-00001 TABLE 1 Phase: Ingredients: Percentage: A Water
58.100 Mega Moist 0.500 N-Acetyl D-Glucosamine 4.000 Mandelic Acid
0.500 Ritaloe 1X 1.000 Citric Acid 0.100 Sodium Citrate 0.300 B
Alcohol 35.000 Phenoyxethanol 0.500 Total Percentage: 100.000
Example 2
Tri-Tightening Complex Formulation B
[0031] Phase A is weighed in a kettle equipped with high speed
agitation. The ingredients and percentage of each ingredient in the
composition is set forth in Table 2 below:
TABLE-US-00002 TABLE 2 Phase: Ingredients: Percentage: A Water
93.100 Mega Moist 0.500 N-Acetyl D-Glucosamine 4.000 Mandelic Acid
0.500 Ritaloe 1X 1.000 Citric Acid 0.100 Sodium Citrate 0.300
Phenoyxethanol 0.500 Total Percentage: 100.00
[0032] The present invention is not limited to the above Examples
and Tables. Numerous modifications and variations of the present
invention are possible in light of the above teachings. It is
therefore to be understood that within the scope of the attendant
claims attached hereto, this invention may be practiced other than
as specifically disclosed herein.
* * * * *